Hemenway Trust Hemenway Trust’s Novo Nordisk NVO Stock Holding History

Hemenway Trust Hemenway Trust’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$421K	Sell	8,774 -3,225	-27%	-$139K	0.03%	90
2026 Q1	$441K	Sell	11,999 -6,091	-34%	-$289K	0.04%	86
2025 Q4	$920K	Sell	18,090 -60,077	-77%	-$3.07M	0.07%	65
2025 Q3	$4.34M	Sell	78,167 -45,561	-37%	-$2.67M	0.33%	42
2025 Q2	$8.54M	Buy	123,728 +60,648	+96%	+$4.13M	0.66%	36
2025 Q1	$4.38M	Buy	63,080 +52,324	+486%	+$4.32M	0.36%	43
2024 Q4	$925K	Sell	10,756 -200	-2%	-$21.6K	0.08%	65
2024 Q3	$1.3M	Sell	10,956 -432	-4%	-$57.6K	0.1%	60
2024 Q2	$1.63M	Hold	11,388	–	–	0.14%	53
2024 Q1	$1.46M	Hold	11,388	–	–	0.13%	54
2023 Q4	$1.18M	Buy	11,388 +1,818	+19%	+$180K	0.11%	57
2023 Q3	$870K	Sell	9,570 -234	-2%	-$20.6K	0.09%	69
2023 Q2	$793K	Buy	9,804 +5,790	+144%	+$473K	0.08%	75
2023 Q1	$319K	Hold	4,014	–	–	0.03%	109
2022 Q4	$272K	Buy	+4,014	New	+$235K	0.03%	119
2016 Q1	–	Sell	-7,084	Closed	-$206K	–	151
2015 Q4	$206K	Sell	7,084 -940	-12%	-$26K	0.05%	149
2015 Q3	$218K	Buy	+8,024	New	+$227K	0.06%	146

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hemenway Trust Hemenway Trust's NVO Position: Q2 2026 in Review

Hemenway Trust Hemenway Trust reduced its Novo Nordisk (NVO) stake by 27% in Q2 2026, selling an estimated $139K and leaving 8,774 shares worth $421K. The position accounts for 0.03% of the portfolio, ranked #90.

Hemenway Trust Hemenway Trust first reported a position in NVO in Q3 2015 and has held it in 17 quarters since. The position peaked at $8.54M in Q2 2025. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Hemenway Trust Hemenway Trust held 8,774 shares of Novo Nordisk worth $421K as of Q2 2026.
Hemenway Trust Hemenway Trust sold 3,225 Novo Nordisk shares in Q2 2026, an estimated $139K.
Novo Nordisk made up 0.03% of Hemenway Trust Hemenway Trust's portfolio in Q2 2026, its #90 holding.
Hemenway Trust Hemenway Trust first reported a position in Novo Nordisk in Q3 2015 and has held it in 17 quarters since.
Hemenway Trust Hemenway Trust's Novo Nordisk position peaked at $8.54M in Q2 2025.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q2 2026, filed 11 Aug 2026.